abstract |
The present invention relates to a new use of a compound of the formula (I) wherein R 1 is NH 2, piperazin-1-yl, 4-methylpiperazin-1-yl, 4-methyl-1,4-diazepan-1- ilo, or 4-ethylpiperazin-1-yl; R2 is hydrogen, fluoro, CH3, CH2CH3, OCH3, CF3 or OCF3; R3 is hydrogen, CH3 or fluoro; as a free base or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for the prevention and / or treatment of bone-related disorders, osteoporosis and intensifying bone formation, bone mineral density. The present invention also relates to a method for the prevention and / or treatment of these disorders. |